dc.contributorUniversity of Tsukuba
dc.contributorUnified Teaching Center of Teresina - CEUT
dc.contributorUniversidade Federal de Minas Gerais (UFMG)
dc.contributorUniversidade Estadual Paulista (UNESP)
dc.date.accessioned2022-04-28T18:58:53Z
dc.date.accessioned2022-12-20T00:53:50Z
dc.date.available2022-04-28T18:58:53Z
dc.date.available2022-12-20T00:53:50Z
dc.date.created2022-04-28T18:58:53Z
dc.date.issued2013-09-01
dc.identifierJornal Brasileiro de Reproducao Assistida, v. 17, n. 5, p. 316-317, 2013.
dc.identifier1517-5693
dc.identifier1518-0557
dc.identifierhttp://hdl.handle.net/11449/219978
dc.identifier2-s2.0-84888329017
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5400107
dc.description.abstractThe current regenerative medicine is still incapable of creating full organs in vitro. Transplantation queues are a worrying problem in most of countries, without an apparent coming solution. The research with several types of stem cells has shown that the use of cells to repair damaged organ can be as effective as replacing the whole organ. Particularly, stem cells populations from the amniotic sac possess properties beyond the physical constitution and are capable of secreting cytokines with anti-inflammatory action and growth factors with potential to mobilize stem cells from the own body. Transplantation of amniotic stem cells can be an alternative to optimize surgical procedures, to increase organ and stem cells transplantation success rate, to help in the treatment of several diseases and to accelerate patient's recovery.
dc.languageeng
dc.languagepor
dc.relationJornal Brasileiro de Reproducao Assistida
dc.sourceScopus
dc.subjectAdult stem cells
dc.subjectAmnion
dc.subjectCytokine
dc.subjectInflammation
dc.subjectOrgan transplantation
dc.titlePropriedades medicinais de células-tronco amnióticas
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución